Riskpilot← Back to searchSign inGet full accessDOIC AB
ABActiveOrg 5568515463Gevärsgatan 11 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 20110 employees
Revenue 2025
SEK 5,3M
+33% vs 2024
EBITDA margin
19.6%
+47% vs 2024
Equity ratio
87.5%
Financial strength
Net profit 2025
SEK 1,1M
+50% vs 2024
| Revenue | SEK 5,3M | +33% |
| EBITDA | SEK 1M | +47% |
| Net profit | SEK 1,1M | +50% |
| Total assets | SEK 20,1M | +6% |
| Equity | SEK 17,6M | +6% |
| Employees | 0 | — |
Legal name
DOIC AB
Org number
5568515463
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 maj 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska förvalta och äga bolag och värdepapper, medicinsk teknisk konsultverksamhet, utbildning och support inom detta område samt därmed förenlig verksamhet.
Address
Gevärsgatan 11 A
Phone
+4642154410
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 736 | 4 793 | 4 227 | 3 960 | 5 256 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 210 | 1 377 | 1 196 | 700 | 1 030 |
| Depreciation & amort. | −0 | — | — | −0 | −0 |
| EBIT | 3 210 | 1 377 | 1 196 | 700 | 1 030 |
| Net financials | 208 | 17 | 7 011 | 227 | 384 |
| Profit before tax | 3 349 | 1 365 | 8 151 | 917 | 1 344 |
| Tax | −229 | −289 | −260 | −206 | −279 |
| Net profit | 3 120 | 1 076 | 7 892 | 711 | 1 065 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 891 | 11 082 | 18 756 | 18 986 | 20 088 |
| Equity | 7 012 | 8 088 | 15 810 | 16 521 | 17 585 |
| Long-term debt | 0 | — | — | 0 | 0 |
| Short-term debt | 699 | 784 | 727 | 366 | 333 |
| Total debt | 699 | 784 | 727 | 366 | 333 |
EBITDA margin
19.6%
This company
15.8%
Market median
+24% vs market
20212025
Equity ratio
87.5%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
6.1%
This company
18.4%
Market median
-67% vs market
20212025
Net profit margin
20.3%
This company
8.1%
Market median
+151% vs market
20212025
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LY Audit | Audit | 2024 |
| Former (1) | ||
CL | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DOIC AB 
Sparvudden Fastighets ABBoard members of DOIC AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Lennart Grundström | Audit | 0 companies |
| Lotta Y S C Hansen | Audit | 0 companies |
| Gun Malin Cecilia Olsson | Deputy Board Member | 0 companies |
| Dan Göte Rikard Olsson | Board of Directors | 0 companies |